Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexpramipexole phase 3 study in amyotrophic lateral sclerosis
2010-022818-19Phase 3Completed
- Sponsor
- Biogen
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in amyotrophic lateral sclerosis (ALS) comparing Dexpramipexole with Placebo (2 arms). Started Jan 2011; status: completed.
02
Drugs
dexpramipexole
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on 2010-022818-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022818-19.